After years on the outer, psychedelic drugs are making a comeback as a legitimate treatment for patients with mental illness - and investors are taking notice.
Psychedelic drugs might be about to become the next medical marijuana for investors. Getty
Psychedelics are approaching a new high. After decades of being stigmatised, they are emerging as a legitimate treatment for psychiatric disorders.
They are also emerging as a legitimate new global market for investment. This may sound like an inversion of the world order, but it’s under way in several countries.
Fetching latest articles
Original URL: https://www.afr.com/policy/health-and-education/investors-pile-in-on-psychedelic-drugs-20200910-p55u52
